Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-03-07 6:00 pm Sale | 2024-03-05 | 13D | Sensei Biotherapeutics, Inc. SNSE | Newtyn Management LLC | 1,242,245 4.950% | -214,428 (-14.72%) | Filing History |
| 2024-02-13 5:34 pm Sale | 2024-02-09 | 13D | Sensei Biotherapeutics, Inc. SNSE | Newtyn Management LLC | 1,456,673 5.830% | -277,485 (-16.00%) | Filing History |
| 2023-11-03 5:03 pm Purchase | 2023-10-25 | 13D | Sensei Biotherapeutics, Inc. SNSE | Newtyn Management LLC | 1,734,158 6.500% | 1,734,158 (New Position) | Filing History |
| 2023-08-04 4:41 pm Sale | 2023-07-31 | 13G | Sensei Biotherapeutics, Inc. SNSE | Cambrian BioPharma Inc | 3,653,120 14.600% | -1,582,836 (-30.23%) | Filing History |
| 2023-06-02 5:00 pm Sale | 2023-06-01 | 13D | Sensei Biotherapeutics, Inc. SNSE | Apeiron Investment Group Ltd. | 0 0.000% | -3,441,661 (Position Closed) | Filing History |
| 2023-05-23 4:50 pm Unchanged | 2023-05-23 | 13D | Sensei Biotherapeutics, Inc. SNSE | Apeiron Investment Group Ltd. | 3,441,661 11.100% | 0 (Unchanged) | Filing History |
| 2023-03-09 5:15 pm Purchase | 2023-03-09 | 13D | Sensei Biotherapeutics, Inc. SNSE | Apeiron Investment Group Ltd. | 3,441,661 11.200% | 2,200 (+0.06%) | Filing History |
| 2023-02-14 11:36 am Purchase | 2022-12-31 | 13G | Sensei Biotherapeutics, Inc. SNSE | Cambrian BioPharma Inc | 5,235,956 17.000% | 4,468 (+0.09%) | Filing History |
| 2022-11-21 06:15 am Unchanged | 2022-11-21 | 13D | Sensei Biotherapeutics, Inc. SNSE | Apeiron Investment Group Ltd. | 3,439,461 11.200% | 0 (Unchanged) | Filing History |
| 2022-11-02 11:58 am Unchanged | 2022-11-02 | 13D | Sensei Biotherapeutics, Inc. SNSE | Apeiron Investment Group Ltd. | 3,439,461 11.200% | 0 (Unchanged) | Filing History |
| 2022-07-19 5:30 pm Purchase | 2022-07-14 | 13D | Sensei Biotherapeutics, Inc. SNSE | Apeiron Investment Group Ltd. | 3,439,461 11.200% | 210,000 (+6.50%) | Filing History |
| 2022-06-10 2:18 pm Purchase | 2021-12-31 | 13G | Sensei Biotherapeutics, Inc. SNSE | Cambrian BioPharma Inc | 5,231,488 17.100% | 5,231,488 (New Position) | Filing History |
| 2022-02-14 3:01 pm Purchase | 2021-12-31 | 13G | Sensei Biotherapeutics, Inc. SNSE | H&S INVESTMENTS I LP | 4,441,624 14.500% | 4,441,624 (New Position) | Filing History |
| 2022-02-10 5:15 pm Purchase | 2021-12-31 | 13G | Sensei Biotherapeutics, Inc. SNSE | Apeiron Investment Group Ltd. | 3,229,461 10.600% | 577,618 (+21.78%) | Filing History |
| 2021-02-18 4:15 pm Purchase | 2021-02-08 | 13G | Sensei Biotherapeutics, Inc. SNSE | Apeiron Investment Group Ltd. | 2,651,843 8.700% | 2,651,843 (New Position) | Filing History |
| 2021-02-16 10:59 am Purchase | 2021-02-03 | 13G | Sensei Biotherapeutics, Inc. SNSE | Peyer James | 4,690,153 15.300% | 4,690,153 (New Position) | Filing History |